Contact Supplier

Contact Supplier

To get in touch with ARTES Biotechnology GmbH, simply fill out the form below.

Subscribe to Supplier

Subscribe to Supplier

Archive | ARTES Biotechnology GmbH

Page 1 of 4
ARTES joins global CV-19 combat with VLP vaccine candidates
ARTES joins global CV-19 combat with VLP vaccine candidates Learn More >
France renews CIR tax credits for ARTES R&D services
France renews CIR tax credits for ARTES R&D services Learn More >
ARTES presenting opportunities for vaccine development at BIO-Europe Spring in Paris
ARTES presenting opportunities for vaccine development at BIO-Europe Spring in Paris Learn More >
45335ARTES VLP-based vaccine development
ARTES VLP-based vaccine development Learn More >
Data on production and immunogenicity of malaria transmission-blocking vaccine candidates published by ARTES and Burnet Institute
Data on production and immunogenicity of malaria transmission-blocking vaccine candidates published by ARTES and Burnet Institute Learn More >
ARTES presenting new development offer at BIOEurope Spring in Vienna
ARTES presenting new development offer at BIOEurope Spring in Vienna Learn More >
44765Recombinant Protein Production and Purification: cell line and process development
Recombinant Protein Production and Purification: cell line and process development Learn More >
ARTES adds SplitCore technology to vaccine development portfolio
ARTES adds SplitCore technology to vaccine development portfolio Learn More >
45334Vaccine development – ARTES
Vaccine development – ARTES Learn More >
ARTES and Minapharm join forces to package biopharma solutions
ARTES and Minapharm join forces to package biopharma solutions Learn More >
45333Recombinant protein production – ARTES
Recombinant protein production – ARTES Learn More >
ARTES successfully completes EU-funded project PLURIVAX
ARTES successfully completes EU-funded project PLURIVAX Learn More >
Page 1 of 4